Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Natural killer cells in human autoimmune diseases.

Schleinitz N, Vély F, Harlé JR, Vivier E.

Immunology. 2010 Dec;131(4):451-8. doi: 10.1111/j.1365-2567.2010.03360.x. Epub 2010 Oct 13. Review.

2.

Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology.

Hao J, Liu R, Piao W, Zhou Q, Vollmer TL, Campagnolo DI, Xiang R, La Cava A, Van Kaer L, Shi FD.

J Exp Med. 2010 Aug 30;207(9):1907-21. doi: 10.1084/jem.20092749. Epub 2010 Aug 9.

3.

Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis.

Söderström K, Stein E, Colmenero P, Purath U, Müller-Ladner U, de Matos CT, Tarner IH, Robinson WH, Engleman EG.

Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13028-33. doi: 10.1073/pnas.1000546107. Epub 2010 Jul 6.

4.

A defective Il15 allele underlies the deficiency in natural killer cell activity in nonobese diabetic mice.

Suwanai H, Wilcox MA, Mathis D, Benoist C.

Proc Natl Acad Sci U S A. 2010 May 18;107(20):9305-10. doi: 10.1073/pnas.1004492107. Epub 2010 May 3.

5.

Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab')2.

Leavenworth JW, Schellack C, Kim HJ, Lu L, Spee P, Cantor H.

Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2562-7. doi: 10.1073/pnas.0914732107. Epub 2010 Jan 21.

6.

Distinct phenotype and function of NK cells in the pancreas of nonobese diabetic mice.

Brauner H, Elemans M, Lemos S, Broberger C, Holmberg D, Flodström-Tullberg M, Kärre K, Höglund P.

J Immunol. 2010 Mar 1;184(5):2272-80. doi: 10.4049/jimmunol.0804358. Epub 2010 Feb 3.

7.

The activating receptor NKp46 is essential for the development of type 1 diabetes.

Gur C, Porgador A, Elboim M, Gazit R, Mizrahi S, Stern-Ginossar N, Achdout H, Ghadially H, Dor Y, Nir T, Doviner V, Hershkovitz O, Mendelson M, Naparstek Y, Mandelboim O.

Nat Immunol. 2010 Feb;11(2):121-8. doi: 10.1038/ni.1834. Epub 2009 Dec 20.

PMID:
20023661
8.

The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium.

Satoh-Takayama N, Dumoutier L, Lesjean-Pottier S, Ribeiro VS, Mandelboim O, Renauld JC, Vosshenrich CA, Di Santo JP.

J Immunol. 2009 Nov 15;183(10):6579-87. doi: 10.4049/jimmunol.0901935. Epub 2009 Oct 21.

9.

How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets.

Feuerer M, Shen Y, Littman DR, Benoist C, Mathis D.

Immunity. 2009 Oct 16;31(4):654-64. doi: 10.1016/j.immuni.2009.08.023. Epub 2009 Oct 8.

10.

Poly I:C-induced activation of NK cells by CD8 alpha+ dendritic cells via the IPS-1 and TRIF-dependent pathways.

Miyake T, Kumagai Y, Kato H, Guo Z, Matsushita K, Satoh T, Kawagoe T, Kumar H, Jang MH, Kawai T, Tani T, Takeuchi O, Akira S.

J Immunol. 2009 Aug 15;183(4):2522-8. doi: 10.4049/jimmunol.0901500. Epub 2009 Jul 27.

11.

Dendritic cell interactions with NK cells from different tissues.

Ferlazzo G, Münz C.

J Clin Immunol. 2009 May;29(3):265-73. doi: 10.1007/s10875-009-9283-y. Epub 2009 Mar 12. Review.

PMID:
19280325
12.

Amplification of autoimmune response through induction of dendritic cell maturation in inflamed tissues.

Melli K, Friedman RS, Martin AE, Finger EB, Miao G, Szot GL, Krummel MF, Tang Q.

J Immunol. 2009 Mar 1;182(5):2590-600. doi: 10.4049/jimmunol.0803543.

13.

Cytokine-induced memory-like natural killer cells.

Cooper MA, Elliott JM, Keyel PA, Yang L, Carrero JA, Yokoyama WM.

Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1915-9. doi: 10.1073/pnas.0813192106. Epub 2009 Jan 30.

14.

Adaptive immune features of natural killer cells.

Sun JC, Beilke JN, Lanier LL.

Nature. 2009 Jan 29;457(7229):557-61. doi: 10.1038/nature07665. Epub 2009 Jan 11. Erratum in: Nature. 2009 Feb 26;457(7233):1168.

15.

Innate immunity and intestinal microbiota in the development of Type 1 diabetes.

Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, Hu C, Wong FS, Szot GL, Bluestone JA, Gordon JI, Chervonsky AV.

Nature. 2008 Oct 23;455(7216):1109-13. doi: 10.1038/nature07336. Epub 2008 Sep 21.

16.

Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production.

Lo CK, Lam QL, Sun L, Wang S, Ko KH, Xu H, Wu CY, Zheng BJ, Lu L.

Arthritis Rheum. 2008 Sep;58(9):2700-11. doi: 10.1002/art.23760.

17.

Critical role for IFN-gamma in natural killer cell-mediated protection from diabetes.

Lee IF, Qin H, Priatel JJ, Tan R.

Eur J Immunol. 2008 Jan;38(1):82-9.

18.

Modification of the tumor microenvironment to enhance immunity.

Liao YP, Schaue D, McBride WH.

Front Biosci. 2007 May 1;12:3576-600. Review.

PMID:
17485323
19.

Reciprocal regulation between natural killer cells and autoreactive T cells.

Shi FD, Van Kaer L.

Nat Rev Immunol. 2006 Oct;6(10):751-60. Review.

PMID:
16998508
20.

T cell- and B cell-independent adaptive immunity mediated by natural killer cells.

O'Leary JG, Goodarzi M, Drayton DL, von Andrian UH.

Nat Immunol. 2006 May;7(5):507-16. Epub 2006 Apr 16.

PMID:
16617337

Supplemental Content

Support Center